Company Overview of AngioDesign Inc.
AngioDesign Inc., a biotechnology company, focuses on the design of drugs for proven disease targets. It designs targeted molecular therapeutics, such as domain-selective angiotensin-converting enzyme inhibitors for cardiovascular and other diseases. The company was incorporated in 2002 and is based in Eagle, Nebraska.
Eagle, NE 68347
Founded in 2002
Key Executives for AngioDesign Inc.
Similar Private Companies By Industry
|Neurogen Corporation||United States|
|PharmatrophiX, Inc.||United States|
|ConjuGon Inc.||United States|
|BioCritica, Inc.||United States|
|AdeptBio LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact AngioDesign Inc., please visit www.angiodesign.com. Company data is provided by Capital IQ. Please use this form to report any data issues.